Engagement of the human interleukin-3 receptor (IL-3R) by IL-3 triggers a variety of cellular signals resulting in the preservation of cell viability, proliferation, and differentiation of hemopoietic cells (4, 27) . Expression of the IL-3R, while subject to regulation, is maintained during hemopoietic cell differentiation, and its activation on the mature cells leads to enhanced function of monocytes (10) , eosinophils (26) , basophils (12, 24) , and neutrophils (44) . The IL-3R has been shown to be expressed also on endothelial cells with activation by IL-3 stimulating cytokine release and the expression of adhesion molecules (20, 21) . The wide expression of the IL-3R on hemopoietic cells and on cells of the blood system suggests roles in hemopoiesis, allergy, atherosclerosis, and chronic inflammation. However, the mechanism of IL-3R activation remains unclear.
The human IL-3R is a heterodimeric receptor consisting of an IL-3-specific ␣ chain (IL-3R␣) (19) and a common ␤ chain (␤ c ) (13) that is also a component of the receptors for granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-5 (reviewed in references 25 and 34) . Both receptor chains belong to the cytokine receptor superfamily (3), although it has been noted that the IL-3R␣ chain is more closely related to the GM-CSF receptor ␣ chain (GM-CSFR␣) and IL-5R␣ chains than to other cytokine receptors (11) . Thus, these three ␣ chains can be recognized structurally and possibly functionally as a distinct subfamily. ␤ c , on the other hand, is structurally more closely related to gp130 and the IL-2R␤ chain (11) and, analogous to these common receptor subunits, it converts lowaffinity ligand binding to high-affinity ligand binding and acts as a signal transducer (29) .
The expression of both IL-3R␣ and ␤ c is necessary for triggering signalling and cellular proliferation in response to IL-3 (18) . Stimulation of cells with IL-3 leads to activation of JAK-2 (38, 43) and Lyn (48) kinases, phosphatidylcholine hydrolysis and protein kinase C translocation (39) , activation of multiple isoforms of the signal transducer protein Stat 5 (1, 30) , and gene expression (52) . Although some form of receptor dimerization has been presumed to take place, the relative contribution of each receptor chain, the nature of their association, and the implications for receptor activation are not known.
Receptor dimerization is recognized to be important for activation in many receptor systems. For example, receptor tyrosine kinases (14, 22, 49) , as well as nontyrosine kinase receptors such as the G-CSFR (16), undergo homodimerization following ligand binding, which leads to signalling. Homodimerization has also been observed in the erythropoietin (EPO) receptor (28) and in a mutant EPO receptor that is constitutively active (53) . IL-6R and ciliary neurotrophic factor receptor (CNTFR) dimerization have also been shown to occur. These receptors are more analogous to the IL-3R in that they consist of a binding subunit and signalling subunits (7, 15) . In these cases, ligand triggers subunit association but only dimerization of the signalling subunits; the signalling subunits, gp130 in the case of IL-6, and gp130 and the leukemia inhibitory factor-binding protein (LIFR) in the case of CNTF, mediate signalling (7, 32) . In the IL-3R, GM-CSFR, and IL-5R system, however, the biochemical evidence of receptor dimerization has been missing. Furthermore, the requirements for the ␣ chain and ␤ c in receptor activation based on cell lines transfected with genetically manipulated receptors is controversial. On the one hand, chimeric receptors consisting of extracellular ␣ chains and intracellular ␤ c allow function in the presence of intact ␤ c and ligand, suggesting that ␤ c dimerization is sufficient for signalling (9, 33, 47) . On the other hand, deletion of the cytoplasmic domain of the ␣ chains abolishes ligand-mediated stimulation, suggesting that an intact ␣ chain may be required for receptor dimerization and signalling (40, 54) . Using primary human cells, we show here that IL-3R␣ and ␤ c undergo dimerization following stimulation with IL-3, and that, unlike the IL-6R and CNTFR, the ␣ chain of the IL-3R is part of the disulfide-and the non-disulfide-linked dimers. Furthermore, the disulfide-linked IL-3R␣-␤ c heterodimer is shown to be required for receptor activation and phosphorylation of ␤ c but not for affinity conversion. Given the conservation of IL-3R␣ with the GM-CSFR and IL-5R␣ chains and the common nature of the ␤ chain, the results presented here may also be applicable to the GM-CSFR and IL-5R.
MATERIALS AND METHODS
Cytokines and cells. Human IL-3, GM-CSF, and the IL-3 mutant E22R were produced in Escherichia coli and purified to homogeneity by reverse-phase highpressure liquid chromatography (2) . Quantitation was performed by integration of peak absorbance of protein stained with Coomassie blue R-250 after sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). IL-3 was radiolabelled with 125 I by the ICl method as previously described (5) . The cells used, unless otherwise indicated, were primary human leukemic cells obtained from the blood of a patient with chronic myeloid leukemia (CML cells) after separation on Ficoll-Paque (Pharmacia). CML cells were T-and B-cell antigen negative, CD33 and CD34 positive, and IL-3R␣, GM-CSFR␣, and ␤ c positive, as judged by flow cytometry with specific monoclonal antibodies (MAb) and then with fluorescein isothiocyanate-conjugated goat anti-mouse immunoglobulin (Ig). The other two types of cells used were the human UT7 cell line and COS cells transfected with IL-3R␣ and ␤ c cDNAs. The ␤ c DNA construct was cloned in pSG5 (gift from S. Barry and R. D'Andrea).
Anti-IL-3R MAb. MAb against the IL-3R␣ and ␤ chains were raised by immunizing mice with COS cells transiently transfected with the IL-3R␣ or ␤ c cDNA and selecting on CHO cell transfectants stably expressing each receptor chain. MAb 9F5 against the IL-3R␣ chain and MAb 4F3 against ␤ c were selected for their ability to provide a strong signal in immunoprecipitation analysis, and MAb 1C1 against ␤ c and MAb 9F5 were selected for giving strong signals on Western blot (immunoblot) analysis. MAb 7G3 is directed against the IL-3R␣ chain and blocks IL-3 binding and IL-3-mediated functions (46) . Each MAb was produced as ascitic fluid and purified by protein G Sepharose. For immunoprecipitation experiments, MAb 9F5 and 4F3 were directly coupled to Sepharose beads by using CNBr-activated Sepharose 4B as previously described (45) .
Antiphosphotyrosine MAb. The MAb against phosphorylated tyrosine was the peroxidase-conjugated antiphosphotyrosine 3-365-10 (Boehringer Mannheim, Frankfurt, Germany).
Fluorescence-activated cell sorting staining. 8 cells in 1 ml of PBS were mixed with 1 mCi of 125 I (NEN) and radiolabelled by the lactoperoxidase method as described previously (50) . Following labelling, the cells were incubated with medium, IL-3, GM-CSF, or IL-3 mutant E22R, for different times before being lysed with lysis buffer composed of 150 mM NaCl, 10 mM Tris-HCl (pH 7.4), 10% glycerol, 1% Nonidet P-40, and protease and phosphatase inhibitors (10 g of aprotinin per ml, 10 g of leupeptin per ml, 2 mM phenylmethylsulfonyl fluoride, and 2 mM sodium vanadate). After 30 min at 4ЊC, the lysate was centrifuged at 10,000 ϫ g for 15 min, and the supernatant was removed, precleared with mouse Ig-coupled Sepharose beads for 18 h at 4ЊC, and incubated with anti-IL-3R␣ MAb, anti-␤ c MAb, or anti-phosphotyrosine-coupled Sepharose beads for 2 h at 4ЊC. The beads were then washed 6 times with lysis buffer before being boiled for 5 min in SDS-PAGE sample buffer and the immunoprecipitated proteins were separated by SDS-PAGE. In some experiments, the alkylating agent iodoacetamide was added to the cells for 20 min at 4ЊC before or after the cells were incubated with IL-3.
SDS-PAGE. Immunoprecipitated proteins were analyzed by one-dimensional (1D) or two-dimensional (2D) SDS-PAGE under reducing and nonreducing conditions. Separation of proteins by 1D SDS-PAGE and reducing conditions utilized 7.5% polyacrylamide linear gels and boiling in SDS sample buffer containing 4% 2-mercaptoethanol. Proteins were separated under nonreducing conditions on SDS-6% polyacrylamide linear gels and the samples were boiled in SDS buffer without 2-mercaptoethanol. Proteins separated by 2D SDS-PAGE were subjected to separation under nonreducing conditions in tube gels followed by separation under reducing conditions in the second dimension (36) . For 1D gels, molecular weights (MW) were estimated with commercially available MW markers (Bio-Rad Broad Range Standards 161-0318). For 2D gels, the MW of the separated proteins were estimated by mixing the I-labelled IL-3. Nonspecific binding was determined from samples containing 1 M unlabelled IL-3. The nonspecific binding component for datum points obtained at lower radioligand concentrations was obtained by interpolation. After incubation at 21ЊC for 2 h with shaking, cell-associated radioligand was separated from free radioligand by overlaying the cell suspension on a 0.2-ml cushion of fetal calf serum and centrifuging for 10 s at maximum speed in a microcentrifuge. The visible cell pellet was removed by cutting, and radioactivity was determined with a Cobra 5010 ␥-counter (Packard, Meriden, Conn.). Dissociation constants were calculated by using the EBDA and LIGAND programs (31) (Biosoft, Cambridge, United Kingdom).
RESULTS

IL-3 induces IL-3R␣ and ␤ c association.
In order to study the molecular events leading to IL-3R activation in primary cells, we developed MAb specific for IL-3R␣ and for ␤ c which could give strong signals in immunoprecipitation and Western blot analyses. From several MAb raised against COS cell transfectants overexpressing IL-3R␣ or ␤ c , three MAb were selected: MAb 9F5 specifically immunoprecipitated IL-3R␣ from stable CHO cell transfectants, while MAb 4F3 immunoprecipitated ␤ c from CHO cells transfected with ␤ c cDNA. These MAb did not react with CHO cells expressing GM-CSFR␣ (data not shown). For Western blot analyses, MAb 9F5 gave a strong signal on CHO cells expressing IL-3R␣ and MAb 1C1 gave the strongest signal on CHO cells expressing ␤ c . These MAb were used to screen several primary myeloid cells; of these cell lines, CML cells obtained from a patient with chronic myeloid leukemia exhibited the largest number of receptor molecules, as judged by flow cytometry, and were therefore used for subsequent experiments (data not shown).
In order to determine whether the IL-3R exists as a preformed complex or is induced by ligand, MAb 9F5 (anti-IL-3R␣) and MAb 4F3 (anti-␤ c ) were used in immunoprecipitation experiments and the proteins were separated on SDSpolyacrylamide gels under reducing conditions. We found that in the absence of IL-3, MAb 9F5 immunoprecipitated only IL-3R␣ and MAb 4F3 immunoprecipitated only ␤ c from (Fig. 1B) . The association of these proteins was rapid and detectable within 30 s. To determine the generality of this phenomenon, we performed further experiments using the human UT7 cell line which expresses IL-3R and COS cells transfected with the IL-3R␣ and ␤ chains. In both cases, IL-3 induced the formation of the heterodimeric complex ( Fig. 2A and B) . The MW of the coimmunoprecipitated proteins suggested that they corresponded to ␤ c when MAb 9F5 was used and to IL-3R␣ when MAb 4F3 was used (Fig. 1) . To test whether this was indeed the case, we performed Western blot analyses using chemiluminescence as the detection method. In addition, and as a specificity control, the cells were incubated with GM-CSF (Fig. 3) . We found that MAb 9F5 immunoprecipitated IL-3R␣ together with a 120,000-MW protein in the presence of IL-3 but not in the presence of GM-CSF (Fig. 3A) . Conversely, MAb 4F3 immunoprecipitated ␤ c and a 70,000-MW protein only in the presence of IL-3 (Fig. 3B) . We consistently found a weak band with an MW of approximately 80,000 coimmunoprecipitating with ␤ c , and other experiments showed that this band represents GM-CSFR␣ (data not shown). To determine the identities of the coimmunoprecipitated bands, we probed the proteins immunoprecipitated with MAb 9F5 (anti-IL-3R␣) by Western blotting with MAb 1C1 (anti-␤ c ), and reciprocally, the proteins immunoprecipitated with MAb 4F3 (anti-␤ c ) with MAb 9F5 (anti-IL-3R␣). These data established that ␤ c coimmunoprecipitated with IL-3R␣ and IL-3R␣ coimmunoprecipitated with ␤ c , but only in the presence of IL-3 (Fig. 3B) .
IL-3R complex formation is dependent on IL-3 contacting both IL-3R␣ and ␤ c . To study whether IL-3 binding to both chains of the IL-3R was a prerequisite for IL-3R complex formation, we performed coimmunoprecipitation experiments after preincubation of the cells with MAb 7G3, which blocks IL-3 binding to IL-3R␣ (46) , and in the presence of the IL-3 mutant E22R, which has defective ␤ c interaction (2) . We found that preincubation of cells with the blocking MAb (7G3) greatly reduced the abilities of the ␣ chain to coimmunoprecipitate ␤ c (Fig. 4A ) and of ␤ c to coimmunoprecipitate with IL-3R␣ in the presence of IL-3 (Fig. 4B) . Experiments comparing the effects of the IL-3 mutant E22R with wild-type IL-3 were performed over a range of ligand concentrations. We found that wild-type IL-3 induced the coimmunoprecipitation of IL-3R␣ and ␤ c at a concentration of 0.1 nM and maximally at 1.0 nM (Fig. 5A and B) . In contrast, the IL-3 mutant E22R did not cause coimmunoprecipitation of IL-3R␣ and ␤ c at concentrations up to 100 nM ( Fig. 5C and D) . At higher concentrations (4 M) of E22R, some coimmunoprecipitation of IL-3R␣ and ␤ c was observed (data not shown). Again, a protein with an MW of approximately 80,000 coimmunoprecipitated with ␤ c in the absence of wild-type IL-3 (Fig. 5B ) or in the presence of E22R (Fig. 5D ) corresponding to GM-CSFR␣. These experiments establish that IL-3 needs to contact both receptor chains in order to trigger receptor ␣ and ␤ c association.
IL-3 induces disulfide-and nondisulfide-linked receptor dimers. To examine the possibility that IL-3 induces the covalent association of IL-3R␣ and ␤ c , we next analyzed the immunoprecipitated proteins under nonreducing conditions. We found that in the absence of IL-3, the anti-IL-3R␣ MAb immunoprecipitated only IL-3R␣ (Fig. 6A) . The anti-␤ c MAb, on the other hand, immunoprecipitated mainly monomeric ␤ c but also consistently immunoprecipitated a faint band with an apparent MW of 245,000 (Fig. 6B) . However, incubation with IL-3 not only led to the coimmunoprecipitation of IL-3R␣ and ␤ c as shown above but also induced the appearance of two high-MW bands with apparent MW of approximately 215,000 and 245,000 (Fig. 6 ). This was observed whether immunoprecipitations were performed with anti-IL-3R␣ MAb (Fig. 6A) or anti-␤ c MAb (Fig. 6B) . The high-MW complexes appeared to be disulfide linked, since treatment with the thiol-specific al- Fig. 6A and B, lanes IAMϩIL-3). Thus, IL-3 induces IL-3R␣ and ␤ c association by covalent and noncovalent means. For controls, we used iodoacetamide after IL-3 treatment in which case little or no reduction in the formation of the high-MW complexes was observed ( Fig. 6A and B, lanes IL-3ϩIAM). Furthermore, the addition of IL-3 to the lysis buffer did not induce IL-3R␣ and ␤ c association ( Fig. 6A and B, lanes lysateϩIL-3), indicating that ␣ and ␤ c association was not induced in solution. These controls demonstrate that the appearance of the high-MW complexes requires free sulfhydryl groups and IL-3 acting on the intact cells. We next examined whether IL-3 itself was present in the immunoprecipitated complexes. We did not perform Western blotting with anti-IL-3 antibodies, since it was possible that IL-3 epitopes could be masked by bound receptor. Instead, we stimulated the cells with radiolabelled IL-3 in the absence or presence of a 100-fold excess of unlabelled IL-3. We found that 125 I-labelled IL-3 could be immunoprecipitated with MAb 9F5 (anti-IL-3R␣) or MAb 4F3 (anti-␤ c ) and this immunoprecipitation was inhibited by excess unlabelled IL-3 (Fig. 6C) . However, IL-3 was not covalently bound to IL-3R␣ or ␤ c , as demonstrated by its migration to the 15,000-MW region (Fig. 6C) .
Significantly, prevention of disulfide-linked dimer formation by iodoacetamide did not affect high-affinity binding of IL-3. Scatchard analysis of cells treated with iodoacetamide showed that high-affinity binding was essentially the same as that seen with untreated cells (Fig. 6D) .
To identify the components of the disulfide-linked high-MW bands, we next performed 2D SDS-PAGE and Western blot analysis. 2D gel electrophoresis of immunoprecipitates from (Fig. 7) . The 215,000-MW band in the nonreduced first dimension was resolved into two spots with MW of 120,000 and 70,000 in the reduced dimension, consistent with the MW of ␤ c and IL-3R␣, respectively. A broad, higher-MW complex in the nonreduced dimension was also resolved into 120,000-and 70,000-MW components, although this was less distinct than for the 215,000-MW complex. These experiments suggested that the two high-MW bands seen under nonreducing conditions contain IL-3R␣ and ␤ c . To examine this identity further, we performed Western blotting of IL-3-stimulated cells immunoprecipitated with anti-IL-3R␣ and anti-␤ c MAb. In the absence of IL-3, no high-MW bands were immunoprecipitated with anti-IL-3R␣ MAb (Fig. 8A) , while a 245,000-MW band could be immunoprecipitated with anti-␤ c MAb (Fig. 8A ) and also contained IL-3R␣ (Fig. 8B) , as judged by Western blotting. After stimulation with IL-3, however, both MAb 9F5 (anti-IL-3R␣) and MAb 1C1 (anti-␤ c ) reacted with the 215,000-and 245,000-MW bands, confirming that IL-3R␣ and ␤ c were both present in these disulfide-linked complexes ( Fig.  8B and C) . IL-3-induced disulfide-linked dimers are required for receptor activation. In order to determine the functional consequences of IL-3R dimerization, we examined the immunoprecipitated complexes for the presence of phosphorylated tyrosine. We performed immunoprecipitations on 125 I-surfacelabelled cells with anti-IL-3R␣ and anti-␤ c antibodies and probed the immunoprecipitates, separated under nonreducing or reducing conditions, with antiphosphotyrosine antibodies by Western blotting. The results showed that the antiphosphotyrosine MAb 3-365-10 reacted strongly with 215,000-and 245,000-MW bands (Ͼ94% of phosphotyrosine), but little label (Ͻ6% of phosphotyrosine) was observed in the 120,000-MW region. This antiphosphotyrosine staining was observed with immunoprecipitates by using either MAb 9F5 (anti-IL-3R␣) or 4F3 (anti-␤ c ) and disappeared when ␣␤ covalent dimer formation was prevented by iodoacetamide (Fig. 9A) . These results show that phosphorylation in response to IL-3 occurs primarily on the covalent ␣␤ heterodimer, suggesting that ␣␤ heterodimer formation is required for cellular activation. To ascertain whether both IL-3R␣ and ␤ c were being phosphorylated, the immunoprecipitates with anti-IL-3R␣ and anti-␤ c MAb were separated under reducing conditions before analysis by Western blotting with the antiphosphotyrosine antibody 3-365-10. Under these conditions, only a phosphorylated band with an MW of about 120,000 was observed, consistent with ␤ c but not IL-3R␣ being the phosphorylated protein present in the receptor dimer (Fig. 9A) .
We further confirmed the predominant phosphorylation of the covalent ␣␤ heterodimer by using the human UT7 cell line (Fig. 9B) . The onset of phosphorylation in the covalent ␣␤ VOL. 16, 1996 MOLECULAR BASIS OF heterodimer was rapid and detectable at 1 min (Fig. 9B) . The proportions of tyrosine phosphorylation in these heterodimers at 1, 5, and 15 min were 91, 87, and 82%, respectively. As with CML cells, the formation of the covalent ␣␤ heterodimer was prevented and tyrosine phosphorylation was abolished by pretreatment of UT7 cells with iodoacetamide (data not shown).
To control for any possible toxic effects of iodoacetamide, UT7 cells were pretreated with this agent and then stimulated with phorbol myristate acetate and calcium ionophore. Under the conditions used, no inhibition of basal or induced tyrosine phosphorylation was observed (Fig. 9C) , indicating that iodoacetamide was not toxic to the cells.
DISCUSSION
We show here that human IL-3 binding to its receptor triggers the heterodimerization of its specific receptor binding subunit, IL-3R␣, with ␤ c and that receptor heterodimerization is dependent on IL-3 contacting both receptor subunits. Both disulfide-linked and non-disulfide-linked heterodimers were observed and, although IL-3 is required for their formation, IL-3 is not covalently attached to the dimers. Importantly, the disulfide-linked heterodimer and not the noncovalently linked heterodimer is shown to be required for receptor activation but not high-affinity binding. These results are different from those in the IL-6, EPO, and G-CSF receptor systems where receptor activation involves homodimerization of a single signalling subunit and may apply also to the related GM-CSF and IL-5 receptors.
Previous experiments have shown that IL-3R activation leads to stimulation of JAK-2 (43) and Lyn (48) kinases, as well as the Ras-mitogen-activated protein kinase, phosphatidylinositol 3-kinase, and protein kinase C pathways (41) . The molecular basis of receptor activation has not been revealed, although by analogy with other receptor systems, it is believed to involve receptor dimerization. Receptor dimerization has been demonstrated in tyrosine kinase receptors (14, 49) , as well as the G-CSFR (16), EPO receptor (28), IL-6R (32), and CNTFR (7) . Dimerization of the IL-3R, GM-CSFR, or IL-5R has been proposed in ligand-induced and ligand-independent receptor activation (6, 17) , but no evidence has been forthcoming. The results presented here demonstrate both covalent and noncovalent dimerization of the receptor, that it involves the ligandbinding subunit dimerizing with ␤ c , and that covalent linkage of dimers is required for signalling. These results emphasize the importance of the ␣ chain not only as a ligand-binding subunit but also as a subunit required for signalling in primary cells. This is consistent with experiments where deletion of the cytoplasmic domain of ␣ chains abolishes signalling (40, 54) . Other experiments have shown, however, that the cytoplasmic domain of ␤ c can substitute for the intracytoplasmic domain of the ␣ chain (9, 33, 47) . The exact significance of these findings is not clear but these findings may reflect the conserved nature of the proline-rich sequence present in the membrane-proximal domain of both the ␣ chain and ␤ c or the fact that at least two molecules of ␤ c are required for signalling, with the role of the ␣ chain being to recruit or facilitate the association of two molecules of ␤ c . Our experiments demonstrating the presence of both IL-3R␣ and ␤ c in the 215,000-and 245,000-MW complexes suggest that a heterodimer containing one ␣ chain and one ␤ c may be sufficient for signalling, although we cannot rule out the existence of higher-MW oligomeric complexes. Definition of the stoichiometry of the active receptor complex would require direct measurements using purified receptor components as shown with the IL-6R (35, 51) .
The presence of IL-3R␣ in the disulfide-linked IL-3R dimers (7), while in the case of the CNTFR, gp130 and LIFR form disulfide-linked dimers (7), events which appear to initiate signal transduction. These findings suggest a fundamental difference in the functional contribution of IL-3R␣ compared with IL-6R␣ and CNTFR␣ in receptor activation and suggest that IL-3R␣ is not only involved in the initial binding of ligand but also participates in signalling. These results are consistent with differences in the requirement for the cytoplasmic domain of the ␣ chains for signalling. Thus, while the cytoplasmic domain of the ␣ chains of the IL-3, GM-CSF, and IL-5 subfamily of receptors are essential for signal transduction (37, 40) , the cytoplasmic portion of IL-6R␣ is not (57) . On the other hand, IL-3R␣ behaves like the LIFR, which participates both in ligand binding and signalling. Human IL-3R heterodimerization upon addition of IL-3 was found to be very rapid (it is complete within 1 min) and dose dependent. An anti-IL-3R␣ monoclonal antibody which inhibits IL-3 binding to this chain (46) prevented IL-3-induced receptor heterodimerization. Similarly, the IL-3 mutant E22R which is selectively deficient at interacting with ␤ c (2) failed to induce receptor dimerization in a concentration range in which wild-type IL-3 did so. This indicates that IL-3 needs to contact both receptor chains to stabilize the complex and induce receptor dimerization.
Under reducing conditions of SDS-PAGE, the IL-3-induced dimers were resolved into monomeric IL-3R␣ and ␤ c . Under nonreducing conditions, however, two high-MW complexes with MW of 215,000 and 245,000 were also seen in immunoprecipitations performed with both anti-IL-3R␣ and anti-␤ c MAb. These were disulfide-linked dimers, as judged by their disappearance in the presence of the thiol-specific alkylating agent iodoacetamide added before but not after incubation with IL-3. In the absence of IL-3, a faint band with an apparent MW of about 245,000 was consistently seen, but only in immunoprecipitations performed with MAb anti-␤ c ( Fig. 6 and  8 ). Western blotting showed that this band contains ␤ c (data not shown) and IL-3R␣ (Fig. 8B ), suggesting that a small proportion of receptors may exist as preformed, though inactive (see below) dimers. IL-3 was present in the IL-3-induced receptor dimers, although it was not disulfide linked to either receptor chain (Fig. 6) .
The sizes of the two high-MW complexes suggested that they might represent IL-3R␣ and ␤ c heterodimers or ␤ c homodimers. By performing 2D SDS-PAGE (Fig. 7) and Western blotting (Fig. 8) experiments, we could show that both IL-3R␣ and ␤ c were present in the 215,000-and 245,000-MW bands. In addition, the 2D SDS-PAGE suggested that higher-MW complexes were also formed. The presence of both IL-3R␣ and ␤ c in these complexes may account for the 215,000-MW band, but the 245,000-MW band may contain another protein in addition to IL-3R␣ and ␤ c . This accessory protein is not IL-3, as IL-3 is not disulfide linked to either receptor chain (see above). It is possible that a third, poorly iodinated surface protein or a small cytoplasmic protein becomes covalently linked to the IL-3R upon activation, but its presence and identity remain to be determined.
The presence of IL-3-induced disulfide-linked and non-disulfide-linked heterodimers suggests two types of IL-3R␣ and ␤ c interaction, a noncovalent one and one that is mediated by Cys-Cys bridging of the receptors. The reason for the presence of both types of complexes or the sequence of their appearance is not clear. It is possible that initially IL-3 binds to IL-3R␣ and the IL-3-IL-3R␣ complex binds ␤ c , forming a high-affinity complex. IL-3 high-affinity binding then triggers a noncovalent association, with both events being mediated by cytokine receptor module 2 (CRM2) in ␤ c (Fig. 10) . The main function of these events may be then to bring IL-3R␣ and ␤ c into close proximity, thus facilitating a proportion of the dimers undergoing disulfide linkage through CRM1 of ␤ c (Fig. 10) . These disulfide-linked dimers are therefore not required for highaffinity binding but instead are then involved in recruiting tyrosine kinases which phosphorylate dimerized ␤ c and intracellular proteins. Alternatively, the association of IL-3R␣ and ␤ c may be primarily covalent, but after SDS-PAGE, a propor- VOL. 16, 1996 MOLECULAR BASIS OF IL-3 RECEPTOR ACTIVATION 3043 tion of this complex is disrupted by intramolecular disulfide bond rearrangement. We found that by preventing disulfide-linked dimer formation, it was possible to dissociate high-affinity binding from receptor activation. Thus, high-affinity binding could take place in the absence of receptor activation ( Fig. 6 and 9 ). It may therefore be possible to construct IL-3 antagonists that retain full high-affinity binding but which are deficient at inducing disulfide-linked dimers. On the other hand, if high-affinity binding inevitably leads to disulfide-linked dimer formation and cellular activation, antagonism of IL-3 may rely largely on compounds that prevent disulfide-linked dimerization.
Two lines of evidence showed that disulfide-linked receptor dimerization is involved in receptor activation. First, the vast majority of the tyrosine-phosphorylated bands immunoprecipitated by anti-IL-3R␣ or anti-␤ c MAb corresponded to the disulfide-linked heterodimers (Fig. 9) . This is even more remarkable when it is considered that while Ͻ17% of the IL-3-dependent IL-3R␣ and ␤ c heterodimers are disulfide linked, Ͼ94% of the tyrosine phosphorylation is associated with these dimers. Second, blocking of the thiol groups with iodoacetamide prevented receptor phosphorylation under conditions that did not affect cell viability and total cellular phosphorylation (Fig. 9C) or high-affinity binding (Fig. 6D) , although we cannot rule out inactivation of JAK-2. This is analogous to the IL-6 receptor, where the presence of gp130 homodimers is accompanied by tyrosine phosphorylation of these proteins (32) . Therefore, the disulfide-linked heterodimerization of IL-3R␣ and ␤ c appears to be essential for tyrosine phosphorylation, which is known to involve the Janus family of tyrosine kinases (43) . Since both IL-3R␣ and ␤ c contain intracellular tyrosine residues, we examined whether both receptor chains were being phosphorylated by reduction of the disulfide-linked dimers with dithiothreitol and probing with antiphosphotyrosine antibodies. This revealed that ␤ c but not IL-3R␣ was the phosphorylated protein in the heterodimers (Fig. 9) . This is consistent with preassociated JAK-2 causing phosphorylation of ␤ c (38, 43) . It should be noted that although disulfide-linked dimerization appears essential for receptor phosphorylation, it is possible that other functions are not affected, and it would be of interest to examine functions, such as proliferation, under conditions that prevent disulfide-linked dimer formation. The identification of the cysteines involved in disulfide formation and their mutation may reveal IL-3 activation pathways that occur independently of this process.
The IL-3-induced appearance of disulfide-linked IL-3R␣ and ␤ c dimers suggests the presence of free Cys in these molecules. Examination of the sequences of IL-3R␣ and ␤ c and modelling of the cytokine receptor modules (11) suggest that IL-3R␣ has two potentially unpaired Cys residues, one in the N-terminal domain at position 52, 68, or 76 and one at position 195 in domain 1 of the CRM (Fig. 10) . Similarly, ␤ c has two potentially free Cys residues, one at position 91, 96, or 100 in domain 1 and one at position 234 in domain 2 of CRM1 (Fig.  10) . It is interesting to note that, in contrast to the ␣ chains, ␤ c has two CRMs. While CRM2 has been implicated in binding IL-3, GM-CSF, and IL-5 (23, 56) , the function of CRM1 is unknown. We hypothesize that this is important for disulfide linkage and suggest that, analogous to the cytoplasmic domain of ␤ c (42), the extracellular region can be viewed as having two functional domains, with CRM2 involved in ligand recognition and nondisulfide-linked heterodimerization (Fig. 10 ) and CRM1 involved in the final activation step which includes ␣␤ disulfide formation.
It is also worth noting that the N-terminal regions of IL-3R␣, GM-CSFR␣, and IL-5R␣ are significantly conserved between each other and are present only in this family of receptors (11) . Although the number of Cys residues in this region varies in IL-3R␣ (3 Cys), GM-CSFR␣ (5 Cys), and IL-5R␣ (1 Cys), all three ␣ chains exhibit one unpaired Cys. This raises the possibility that these unpaired Cys residues are involved in disulfide-linked dimerization and suggests a functional reason for the conservation of this N-terminal region in the IL-3R␣, GM-CSFR␣, and IL-5R␣ family. 
